Source - RNS
RNS Number : 3508K
Applied Graphene Materials PLC
10 April 2018
 

 

 

 

10 April 2018

 

Applied Graphene Materials plc

 

("Applied Graphene Materials", "the Group" or "the Company")

 

Interim results for the six months ended 31 January 2018

 

Applied Graphene Materials, the producer of specialty graphene materials, is pleased to announce its interim results for the period ended 31 January 2018.

 

Operational highlights

·     Significant commercial progress within the coatings sector with a number of key customers:

HMG Paints Limited successfully completed real world trials in conjunction with a key customer;

James Briggs Limited, in conjunction with Applied Graphene Material (AGM), is continuing an accelerated product development programme with a view to early market exploitation of graphene; and

good progress with other key accounts governed by strict confidentiality.

·     Increasing commercial momentum in the composites sector, including:

Magna Exteriors, a tier 1 automotive supplier, looking to incorporate AGMs' graphene into products following the successful launch of the Fenyr supercar;

further sector penetration of graphene enhanced products into new markets by SHD Composites Limited; and

collaboration programme with Airbus Space and Defence has been extended to incorporate additional applications. Adoption still anticipated in 2018.

·     Customer launches Graphenics® range of oil based products to target customers.

·     Structural Ink® programme is making significant progress with test printing and evaluation ongoing.

·      Launch of Genable®, a range of products specifically designed for the coatings industry.

·      Further patent applications filed for AGM dispersions.

 

Financial overview

·      EBITDA*                                Loss of £2.0 million (2017: loss of £2.0 million)                         

·      Loss before tax                    Loss of £2.3 million (2017: loss of £2.1 million)

·      Cash at bank                        £12.0 million (2017: £5.6 million)

·      Diluted EPS                          Loss of 6.4 pence per share (2017: loss of 9.3 pence)

 

·      Completion of placing and open offer raising £9.77m (before expenses) of funds for the business.

·      Successfully secured two separate grants relating to the development of graphene based products.

 

* EBITDA comprises loss on ordinary activities before interest, tax, exceptional costs, depreciation and amortisation.

 

Jon Mabbitt, Chief Executive Officer, commented:

"In recent months we have seen increased commercial momentum in our core markets with a number of key collaborations now reaching the final stages of approval. In particular for coatings, the combination of our technical expertise, extensive data generation and the launch of standardised customer ready dispersions under the Genable® brand earlier in the year are supporting potential commercial adopters to accelerate their product testing and qualification processes.

 

Within the composites sector, significant interest is being shown in Structural Ink® and during the current year we expect to accelerate the technology's commercial programme. Opportunities within the sector vary immensely, both in application and quantum, but ultimately the automotive and aerospace industries offer the greatest long-term potential. As such, the progress made with Magna Exteriors and with Airbus Space and Defence is particularly encouraging.

 

Elsewhere, long-term engagements within the functional materials sector are beginning to reach the point of commercialisation and nowhere is this more evident than the collaboration work we have completed with Puraglobe, as they look to launch a graphene enhanced product to their key customers.  

 

With solid foundations in place and well-established collaborations ongoing, the Board remains confident that we have the right strategy in place for the long-term success of the business. Whilst the majority of our collaborations have yet to materialise into top line returns, given the progress that is now being made on many fronts in our key target sectors, we are confident that these will soon deliver real growth."          

 

                                                                                                Ends

 

 

 

 

 

 

 

 

 

Applied Graphene Materials' results presentation, with audio commentary, will be available on our website at http://www.appliedgraphenematerials.com by 17 April 2018.

 

 

 

For further information, please contact:

 

Applied Graphene Materials                                                                            +44 (0) 1642 438 214

Jon Mabbitt, Chief Executive Officer

Gareth Jones, Chief Financial Officer

 

N+1 Singer                                                                                                           +44 (0) 207 496 3000

Richard Lindley / James White

 

Hudson Sandler                                                                                                  +44 (0) 207 796 4133

Charlie Jack / Emily Dillon

Notes to Editors

Applied Graphene Materials was founded by Professor Karl Coleman in 2010 with its operations and processes based on technology that he initially developed at Durham University.  The Group is based at the Wilton Site on Teesside and was admitted to AIM in November 2013.

The Group has developed proprietary bottom-up processes which are capable of producing high purity graphene nanoplatelets using a continuous process. The manufacturing processes are based on sustainable, readily available raw materials and therefore do not rely on the supply of graphite, unlike a number of other graphene production techniques. Applied Graphene Materials owns the intellectual property and know-how behind these processes.

Applied Graphene Materials works in partnership with its customers using its knowledge and expertise to provide bespoke graphene dispersions and formats to deliver enhancements and benefits for a wide range of applications.

 

 

 

 

 

 

 

 

 

 

 

 


Business review

 

 

 

Overview

In the first six months of this financial year, the business has made significant operational progress and is in an excellent position to further capitalise on the strong commercial pipeline it has built. With over 100 active customer engagements, we are now making notable progress on multiple collaborations. Following the first production orders in 2017, SHD Composites has continued to expand sales of its own products containing graphene into sports goods, medical components and most recently the automotive sector, with customers including Magna International, a leading global automotive supplier. Our relationship with Airbus Space and Defence has been extended to include a second material qualification and we expect both products to be used on satellites in outer space, with first flight applications scheduled for later this year.

 

The speed of market penetration and timing of product launch are ultimately dependent on our customers' qualification and adoption timeframes for products containing graphene. However, as we continue to see greater market traction we believe our collaborative approach will support sustainable growth for a high-margin business.

 

With the launch of Structural Ink® we have a material technology which we can sell directly to end specifiers. In March, this was showcased at the JEC World Exhibition in Paris, the premier composites show attended by over 42,000 visitors from 115 countries, where it was clear that graphene is now consistently featured in composites innovation. The demonstration equipment generated significant interest across a spectrum of industries, from F1 to aerospace and wind energy to sports goods. As we scale this up further over the next few months, we expect to be in a position to start selling composite materials printed with graphene to customer specifications from a pilot plant to customers during 2018.

 

AGM remains singularly focused on exploiting the application technology arising from its proprietary manufacturing processes and graphene formulation know-how. We have continued to invest in our raw material production facility and in our dispersion methods. To this end we have extended our patent portfolio based around specific applications of graphene in corrosion prevention. We have focused on formatting our products, such that they are more readily adoptable by our customers, and critically providing the data sheets to demonstrate their consistency and stability. In February, we launched a standard range of graphene dispersions called Genable®. This is primarily targeted at the coatings industry, and designed to provide paint chemists with a standardised consistent product, underpinned with quantified performance data with which to formulate products containing graphene. This benefit is already being appreciated by the likes of HMG Paints Limited (HMG) and James Briggs Limited (JBL) and we believe will facilitate more rapid adoption of graphene technology in their products.

 

In November 2017, AGM successfully raised additional investment of £9.77million (before expenses) which will enable the Company to progress towards financial independence as we commercialise our offering. This was an important step, and the support from both existing and new shareholders was recognition of the progress made to date and demonstrated confidence in our ability to deliver on our potential.

 

In February 2018, AGM also announced that I will be stepping down as CEO of the Company to retire. The search for my successor is already well advanced and I am confident that, with the strong operational platform and relationships in place and commercial momentum steadily building, AGM will continue to deliver on its strategy. I am pleased to say that the senior management team in place is highly experienced and supported by a very strong commercial and technical team, in which we also invested during the year.

 

Commercial progress 

Within our core target market sectors of coatings, composites and functional materials, where we see significant opportunity and where we believe the characteristics of AGM's graphene will deliver the most desirable enhancements, we have continued to develop our commercial pipeline. It is here we also believe that our graphene will add the most value in a non-disruptive manner. We have identified that a graphene loading level of less than 1% by weight in a final product delivers the most compelling material improvements. At extremely low loading levels the customer benefits from minimal intrusion into the rest of the formulation and can afford to put graphene into a broader range of applications than had originally been considered. For us, this means that greater market opportunities are accessible and pricing levels are more robust.

 

Our focus remains on converting opportunities within the existing pipeline, yet at the same time establishing new joint development agreements and collaborations within our core markets. Whilst the vast majority of our customer engagements remain subject to commercial confidentiality, we are able to share progress being made by some of the early potential adopters. As we, and our customers, progressively better understand the mechanisms of property translation from the nano- to the macro-level, so too can we both better identify the true potential of graphene. The properties that graphene possesses will support both the substitution of existing additives already being used at much higher loading levels (such as carbon black at 5-30% by weight) and the delivery of additional functionality without negatively affecting other properties, such is the benefit of a highly structured additive with a massive specific surface area.

 

 

Coatings

Application areas are wide ranging within the coatings sector and include marine, aerospace, automotive, industrial and structure protection. In 2013, the value of the anti-corrosion coatings market was around £8.1 billion worldwide, with primers representing approximately £1.4 billion. We have demonstrated that the inclusion of graphene into existing formulations significantly improves barrier properties, particularly within primer layers and also in hostile environments. Inevitably, once demonstrated, our customers want to replicate this performance in their own products to ensure consistency and reliability in their own specific circumstances, before launching products whose performance they will warrant. Within our pipeline of existing engagements there are numerous customers who are undergoing this type of validation, which in some cases can mean up to 10,000 hours of protection testing.

 

HMG is one of our customers that has completed this verification work to its satisfaction, and this has resulted in it applying the finished product to real applications. The product has been validated in field tests by one of its key customers and it is now looking to launch the product in the near future. Encouraged by this success, HMG has gone on to engage with other existing customers and is in the process of looking to include graphene in its product range.

 

AGM and JBL are continuing an accelerated product development programme with a view to early market exploitation of graphene.  Under the JDA, JBL will incorporate graphene material into existing paint formulations to deliver higher-performing primers with improved corrosion protection.

 

AGM has identified that not only is its graphene able to decelerate the corrosion of steel substrates, but also that it is well suited to aluminium and reinforced plastics where moisture ingress causes deterioration of the fibres. This characteristic is beginning to open up other areas of the coatings market with customers where we already have some engagement.

 

The usefulness of graphene in coatings is not limited to the primer layer or hostile environments. Due to the mechanical properties of the material some of our customers are discovering that they can reduce film thicknesses and still deliver the same performance. There are multiple benefits to this approach, both in terms of logistics and material costs. We have also seen that the electrical conductivity of coatings can be improved by a small addition of graphene which can deliver benefits in anti-static applications, such as floor coatings and in the e-coat process, used widely in the automotive industry.

 

 

Composites

The composites market is worth in excess of €70 billion per annum, of which over 50% relates to component materials. AGM's management team has in-depth knowledge and strong relationships across the sector where we are vigorously pursuing a multichannel approach. The main driver for inclusion of graphene has been to improve the toughening of the resin matrix, and this can be introduced at various stages. Bulk resin manufacturers are investigating how their materials can benefit from the addition of graphene, as are the intermediate material conversion companies such as prepreggers, resin infusion formulators and pultruders.

SHD Composites Limited has already launched standard prepreg materials and has been supplying these to end users, ranging from a manufacturer of orthotics to sports goods suppliers, and very recently to Magna Exteriors for use on the Fenyr supercar, which was launched at the Geneva Motor Show in March. Encouraged by the performance of the material, Magna, a $36 billion revenue, tier 1 automotive supplier, in conjunction with AGM, is now looking to take the graphene technology further. The aim of the collaboration team is to build on the baseline mechanical enhancements and ultimately move towards designing many of graphene's multifunctional capabilities on joint development programmes.  

A report on a demonstrator aircraft wing section containing AGM graphene by the University of the West of Scotland, which worked in partnership with Spirit Aerostructures and a sector-leading bulk resin and carbon fibre company, has demonstrated significant uplifts in key design parameters of fracture toughness and interlaminar shear strength. The panels were infused using aerospace approved processes and properties measured according to ISO standard testing. The benefits demonstrated will allow designers to rely on higher material performances and thereby use less materials in construction, which in turn will lead to weight savings and construction cost savings. The augmentation of material properties will benefit all application areas and a Sit-Ski project was run as a technology demonstrator by the UK's High Value Manufacturing Catapult, with components being manufactured by the Advanced Manufacturing Research Centre (AMRC), the Manufacturing Technology Centre (MTC) and the National Composites Centre (NCC). The project applied the latest in UK R&D composite know-how, including the incorporation of AGM graphene, to make the Sit-Ski faster and lighter and, most crucially, to maximise performance.

Structural Ink® is a patented technique which AGM has developed for selectively depositing graphene onto composite materials via traditional printing techniques. This was showcased at the JEC World show in March and created real interest from end-users, specifiers and material/equipment suppliers. We are installing at least one demonstration cell at the AMRC in Sheffield in the next few months with a view to having production capacity ready later this year. This will enable us to add graphene to our customers' existing composite materials and be capable of selling turn-key equipment packages to customers where demand is greater. In contrast to being reliant on our customers dictating the timing of adoption in their products, Structural Ink® allows us to sell product directly to specifiers. We are already working under JDAs with a number of businesses including Prodrive Composites, which supplies to the high-end automotive, motorsport, aerospace and leisure goods sectors, and by placing a demonstration cell at AMRC we will have the ideal shop window and ready access to AMRC's impressive membership partners.

 

Airbus Space and Defence has extended its qualification efforts of a bespoke material for use on its satellites to include a second product that can be used in a broader range of production techniques. Both materials are expected to be used in outer space, with first flight applications scheduled in the second half of this year.

 

On the back of this work we have launched a new graphene-enhanced thermal paste material - Genable® 4400. The new product will be supplied as a two-part epoxy system andis designed for use in thermally conductive applications, either directly as a paste gap-filling system or as a potential base additive to other formulated systems. Genable® 4400 will provide thermal conductivity and good levels of lap shear strength. We anticipate applications within formulations for bonding, potting, sealing and encapsulation for space, electronics and automotive components.

 

Functional materials

AGM's collaboration with Puraglobe on the exploitation of graphene-enhanced sustainable base oils has now reached the point of commercialisation. Following an extensive development programme and performance testing, Puraglobe has recently launched its Graphenics® range to target customers and is currently engaged in several product development projects, the exact applications of which remain confidential.

Graphenics® is targeted at innovative lubricant technology businesses for applications as broad as gear oil, metal working and driveline fluids. The products are designed to offer finished lubricant manufacturers significant benefits by providing greater protection against friction and wear, which ultimately will extend the lifecycle of parts and reduce the downtime of equipment. This synergistic effect leads to savings in manufacturing and production costs and reduces the demand for replacement parts.

 

Technology and manufacturing

As a technology business it is vital that we continually look to develop our understanding and where applicable look to protect any proprietary knowledge. In September 2017 we were notified that our European patent application in relation to our manufacturing process had been approved. Since then we have continued to develop our understanding in a number of key areas and as a direct result of this work additional patent applications have been filed, specifically in relation to the application processes. Utilising these processes, AGM has the ability to produce nanoplatelets to suit the specific application through our range of manufacturing techniques and formulation know-how. This in turn has a significant impact on the graphene's properties as it enables us to tailor the product in order to optimise the key properties for the application in question.

 

We continue to refine and where appropriate improve our production processes and continually look to make further progress on production yields. This has enabled us to design a programme that will allow us to expand capacity through the addition of modular units which gives us the potential to better match production capacity to the anticipated levels of demand. This approach is highly flexible and more capital efficient than the expansion process we had originally envisaged. We have established robust control systems and have proven our ability to scale up the processes without detriment to product quality.

 

Outlook

Our primary focus remains the targeting of additional and ever larger production orders as momentum increases towards commercialisation. Putting formatted graphene into our customers' hands which can be readily adopted into their production processes with minimal disruption and deliver performance enhancement benefits is a key element in this approach. The manufacturing excellence and technical know-how we have developed, coupled with the support philosophy which runs throughout the Company, provides us with the cornerstones on which commercial success will be built. We are confident that the business will continue to move forward at an ever-increasing velocity to exploit the significant commercial opportunities offered by our target sectors. Our intent remains to become a global graphene market leader and the Board believes that Applied Graphene Materials remains well placed to meet its ambitions.

 

 

 

Jon Mabbitt                                                                         

Chief Executive Officer       

 

10 April 2018


Financial review

 

 

Revenue

Revenue for the period was £54,000 (2017: £53,000) arising from the supply of production orders of graphene and evaluation quantities of graphene to commercial partners.

 

Other income

Other income, which comprises grant income, was £30,000 (2017: £115,000). Grants received related to funding for the development of new graphene applications, with a small amount for the creation of new jobs or the purchase of assets.

 

Loss on ordinary activities before tax

A loss on ordinary activities before tax of £2,291,000 (2017: loss of £2,053,000) was recognised. The current year loss includes exceptional costs of £205,000 mainly connected to fees paid in relation to the issue of new shares.

 

Loss on ordinary activities before interest, tax, exceptional costs, depreciation and amortisation (EBITDA)

EBITDA for the Group reduced from a loss of £1,957,000 in 2017 to a loss of £1,952,000 for the period ended 31 January 2018. The losses incurred in the period relate to the day to day costs of the business and include the ongoing costs associated with the technical input provided to our commercial partners as they look to evaluate and incorporate graphene into their product lines.

 

Exceptional costs

Exceptional costs recognised in the period were £205,000 (2017: £nil). The current year costs principally relate to fees paid in relation to the issue of new shares in that period.

 

Net finance income

Net finance income for the period was £20,000 (2017: £22,000).

 

Loss on ordinary activities before tax, exceptional costs and amortisation (PBTA)

PBTA for the period increased from a loss of £2,053,000 in 2017 to a loss of £2,086,000 for the period ended 31 January 2018.

 

Tax

The Group has not recognised any tax assets in respect of trading losses arising in the current financial year or accumulated losses in previous financial years. The tax credit recognised in respect of the previous financial year arises from the receipt of R&D tax credits. In due course, the Group expects to receive R&D tax credits in respect of other financial years.

 

Earnings per share

Diluted earnings per share was a loss of 6.4 pence per share (2017: loss of 9.3 pence per share). Adjusted diluted earnings per share (before exceptional costs) was a loss of 5.8 pence per share (2017: loss of 9.3 pence per share).   

 

Dividend

No dividend has been proposed for the period ended 31 January 2018 (2017: £nil).

 

Cash flow

Net cash used in operations was £1,998,000 (2017: £2,040,000). During the period, net working capital utilised reduced by £21,000 (2017: increase of £161,000).

 

Capital expenditure of £132,000 (2017: £272,000) has been incurred in the period mainly relating to the development of the production process and related production assets. Net proceeds arising from the issue of shares totalled £9,369,000 (2017: £145,000).

 

Balance sheet

Net assets have increased to £13,284,000 (2017: £6,682,000), principally reflecting the cash generated from the issue of shares offset by the trading loss for the period.

 

Cash at bank at 31 January 2018 was £11,961,000 (2017: £5,554,000).  Monies are on deposit with a small number of financial institutions for time periods ranging between instant access and up to one year in maturity.

 

Accounting policies

The Group's consolidated financial information has been prepared in accordance with International Financial Reporting Standards as adopted in the EU. The Group's significant accounting policies, which are consistent with those set out in the audited financial statements for the year ended 31 July 2017, have been applied consistently throughout the period.

 

Principal risks and uncertainties

Risk management forms an integral part of the business planning and review cycle. The Directors believe the following risks to be the most significant for potential investors. However, the risks listed do not necessarily comprise all of those associated with an investment in the Group and are not set out in any specific order or priority. Additional risks and uncertainties not currently known to the Directors, or which the Directors currently deem not to be significant, may also have an adverse effect on the Group and the information set out below does not purport to be an exhaustive summary of the risks affecting the Group. The Group's performance could be affected by changes in market or economic conditions and in legal, regulatory or tax requirements.

 

Broadly, risks are categorised into seven types: strategic and planning; financial and IT; operational and quality; technical; SHE and regulatory; commercial and reputation; and people. Significant risks facing the Group include:

·      Acceptance of the Group's products - early stage of operations and acceptance of graphene. The Group is at an early stage of development and the success of the Group will depend on the acceptance and attribution of value to graphene produced by the business. Timescales to the successful development of applications for graphene are significantly determined by the product development cycle of customers. There can be no guarantee that either acceptance of graphene or attribution of value will be forthcoming.

·      Intellectual property - the Group's business is based on a combination of patent applications and know-how. The Group's success will depend in part on its ability to maintain adequate protection of its intellectual property and know-how. There is no certainty that patent applications will be granted, that such applications and know-how will be a source of competitive advantage to the Group, or that others have not developed similar or better applications or know-how. Significant costs may be incurred in asserting intellectual property rights and there is no certainty that intellectual property could not become known in a manner (for example, cyber-attack) which may provide the Group with no recourse.

·      Adequacy of financial resources - the available funding required to support the business through to profitability and cash generation may be insufficient. The Group may be unable to access additional debt or equity capital, or to raise funds on acceptable terms. In the event that the resources available to the Group are inadequate then this could have a materially adverse impact on the implementation of the Group's strategy, its business, financial condition and operations.

·      Financial, operational and management information systems - the efficient operation and management of the Group depends on the proper operation and performance of financial, operational and management information systems. Any failure in such systems via a cyber-attack may result in a loss of control and adversely impact the Group's ability to operate effectively.

·      Safety, health and environment - the Group's operations are subject to numerous safety, health and environmental (SHE) and regulatory requirements, both in the UK and overseas, which are likely to become more complicated, stringent and onerous as the Group grows or as time passes. Failure to comply in any way with SHE or regulatory requirements could result in the Group being unable to manufacture or supply graphene, incurring significant costs and liabilities, or being subject to claims and lawsuits which could adversely affect its operations and financial condition. Graphene is also a relatively new material with a limited number of studies having been undertaken into its effects on biological systems. If evidence emerges that graphene has a deleterious effect, then this may adversely impact the Group's business and financial position.

·      Key personnel - the Group has in place an experienced and motivated senior management team and is beginning to build strength in depth. If the Group is unable to attract and retain suitably skilled and qualified people, then the Group's performance and prospects may be adversely impacted. The loss of one or more key personnel could have an adverse impact on the Group's operations, reputation, relationships and future prospects.

 

Cautionary statement
The Business and Financial reviews have been prepared for the shareholders of the Company, as a body, and no other persons. Their purpose is to assist shareholders of the Company in assessing the strategies adopted by the Group and the potential for those strategies to succeed, and for no other purpose. The Business and Financial reviews contain forward-looking statements that are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in the Business and Financial reviews will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation.

 

 

Gareth Jones

Chief Financial Officer

 

10 April 2018


Consolidated income statement and statement of comprehensive income

for the six months ended 31 January 2018
















Note

Revenue

5

54

53

97

Other income

 

30

115

168

 

 

84

168

265

Cost of sales

 

(120)

(189)

(385)

Gross loss

 

(36)

(21)

(120)

Operating expenses

 

(2,275)

(2,054)

(4,190)

EBITDA

 

(1,952)

(1,957)

(4,059)

Exceptional costs

 

(205)

-

-

Depreciation of tangible fixed assets

 

(154)

(118)

(251)

Operating loss

 

(2,311)

(2,075)

(4,310)

Net finance income

 

20

22

33

PBTA

 

(2,086)

(2,053)

(4,277)

Exceptional costs

 

(205)

-

-

Loss on ordinary activities before tax

5

(2,291)

(2,053)

(4,277)

Tax on loss on ordinary activities

3

-

-

1,234

Loss for the period attributable to equity shareholders

 

(2,291)

(2,053)

(3,043)

Other comprehensive income

 

-

-

-

Total comprehensive loss

 

(2,291)

(2,053)

(3,043)





Earnings per share (pence per share)

 

 

 

 

Basic

6

(6.4)

(9.3)

(13.8)

Diluted

6

(6.4)

(9.3)

(13.8)





 

EBITDA comprises loss on ordinary activities before interest, tax, exceptional costs, depreciation and amortisation.

 

PBTA comprises loss on ordinary activities before tax, exceptional costs and amortisation.


 

Consolidated statement of changes in shareholders' equity

for the six months ended 31 January 2018
























As at 31 July 2016

437

18,243

1,231

(11,399)

8,512

Comprehensive loss

-

-

-

(2,053)

(2,053)

IFRS 2 share based payments

-

-

-

78

78

Issue of shares (net)

5

140

-

-

145

As at 31 January 2017

442

18,383

1,231

(13,374)

6,682

Comprehensive loss

-

-

-

(990)

(990)

IFRS 2 share based payments

-

-

-

114

114

Issue of shares (net)

4

258

-

-

262

As at 31 July 2017

446

18,641

1,231

(14,250)

6,068

Comprehensive loss

-

-

-

(2,291)

(2,291)

IFRS 2 share based payments

-

-

-

138

138

Issue of shares (net)

543

8,826

-

-

9,369

As at 31 January 2018

989

27,467

1,231

(16,403)

13,284

 


Consolidated balance sheet

as at 31 January 2018














Note

Assets

 

 

 

 

Non-current assets

 

 

 

 

Intangible assets

 

139

97

138

Property, plant and equipment

 

1,913

1,575

1,936

 

 

2,052

1,672

2,074

Current assets

 

 

 

 

Inventories

 

38

38

45

Trade and other receivables

 

168

234

151

Cash

 

11,961

5,554

4,708

 

 

12,167

5,826

4,904

Liabilities

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

(935)

(816)

(910)

 

 

(935)

(816)

(910)

Non-current liabilities

 

 

 

 

Provisions for other liabilities and charges

 

-

-

-

 

 

-

-

-

Net assets

 

13,284

6,682

6,068

Shareholders' equity

 

 

 

 

Called up share capital

8

989

442

446

Share premium account

 

27,467

18,383

18,641

Merger reserve

 

1,231

1,231

1,231

Retained earnings

 

(16,403)

(13,374)

(14,250)

Equity shareholders' funds

 

13,284

6,682

6,068

 


Consolidated cash flow statement

for the six months ended 31 January 2018















Unaudited

Audited



6 months to

year ended



31 January

31 July



2017

2017


Note

£'000

£'000

Operating activities

 

 

 

 

Net cash used in operations

7

(1,998)

(2,040)

(3,962)

Net finance income

 

15

19

52

Tax received

 

-

-

1,234

Net cash used in operating activities

 

(1,983)

(2,021)

(2,676)

Investing activities

 

 

 

 

Purchase of intangible assets

 

(1)

-

(41)

Purchase of property, plant and equipment

 

(132)

(272)

(684)

Net cash used in investing activities

 

(133)

(272)

(725)

Financing activities

 

 

 

 

Net proceeds from issue of Ordinary shares

 

9,369

145

407

Net cash generated from financing activities

 

9,369

145

407

Net increase/(decrease) in net cash and cash deposits

 

7,253

(2,148)

(2,994)

Net cash and cash deposits at 31 July 2017

 

4,708

7,702

7,702

Net cash and cash deposits at 31 January 2018

 

11,961

5,554

4,708

 

Net cash and cash deposits include:

 

 

 

 

Cash deposits (maturity greater than three months)

 

-

-

-

Cash (maturity less than three months)

 

11,961

5,554

4,708

Net cash and cash deposits at 31 January 2018

 

11,961

5,554

4,708


Notes to the Interim Report

for the six months ended 31 January 2018

 

 

 

1 General information

The principal activity of Applied Graphene Materials plc is the manufacture, dispersion and development of applications for graphene. The Group operates principally in the United Kingdom.

 

The Company is incorporated and domiciled in the United Kingdom and its registered number is 8708426. The address of the registered office is The Wilton Centre, Redcar, Cleveland TS10 4RF. The Company was incorporated on 27 September 2013.

 

The interim financial information was approved for issue on 10 April 2018.

 

2 Basis of accounting

The consolidated interim financial information for the period ended 31 January 2018 has been presented under the historical cost accounting convention, as modified by financial assets and liabilities at fair value through the income statement and share based payments at fair value, and in accordance with International Financial Reporting Standards (IFRS) as adopted by the European Union, IFRIC interpretations and those parts of the Companies Act 2006 applicable to companies reporting under IFRS. The consolidated interim financial information has been prepared on a going concern basis.

 

The accounting policies used in the consolidated interim financial information are consistent with those set out in the audited financial statements for the year ended 31 July 2017. Further IFRS standards or interpretations may be issued that could apply to the Group's financial statements for the year ending July 2018. If any such amendments, new standards or interpretations are issued, then these may require the consolidated financial information provided in this report to be changed. The Group will continue to review its accounting policies in light of emerging industry consensus on the practical application of IFRS.

 

The preparation of financial information in conformity with IFRS requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, events or actions, actual events ultimately may differ from those estimates.

 

The consolidated interim financial information does not include all financial risk management information and disclosures required in the annual financial statements.

 

The consolidated interim financial information for the six months ended 31 January 2018 and for the six months ended 31 January 2017 contained within the Interim Report does not constitute statutory financial statements within the meaning of Section 434 of the Companies Act 2006 and is unaudited. The comparative figures for the year ended 31 July 2017 have been extracted from the audited financial statements, on which the Company's auditors have given an unqualified opinion.

 

3 Taxation

The Group has not recognised any tax assets in respect of trading losses arising in either the current financial year or accumulated losses in previous financial years. The tax credit recognised in respect of the previous financial year arises from the receipt of R&D tax credits.

 

4 Dividends

No dividend has been proposed for the period ended 31 January 2018 (2017: £nil).

 

5 Segmental analysis

The Group currently has one operating segment. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the Chief Operating Decision Maker (CODM) in deciding how to allocate resources and in assessing performance. The Group's Chief Executive Officer has been identified as the CODM. Revenue and profits arising from that operating segment are the same as presented on the face of the consolidated income statement and statement of comprehensive income.



6 Earnings per share

Basic earnings per share is calculated by dividing the earnings attributable to ordinary shareholders by the weighted average number of shares in issue during each period. The weighted average number of shares in issue during the period used in the calculation of basic earnings per share was as follows:

 


Unaudited

Audited


6 months to

year ended


31 January

31 July


2017

2017


'm

'm

Weighted average number of shares for basic earnings per share

36.0

22.1

22.1

 

Adjusted earnings per share has been calculated so as to exclude the effect of exceptional costs including related tax charges and credits. Adjusted earnings used in the calculation of basic and diluted earnings per share reconciles to basic earnings as follows:

 


Unaudited

Audited


6 months to

year ended


31 January

31 July


2018

2017

2017


£'000

£'000

Basic earnings

(2,291)

(2,053)

(3,043)

Adjustments for taxation

-

-

-

Exceptional costs

205

-

-

Adjusted earnings

(2,086)

(2,053)

(3,043)





Earnings per share (pence per share)

 

 

 

Basic

(6.4)

(9.3)

(13.8)

Diluted

(6.4)

(9.3)

(13.8)





Adjusted earnings per share (pence per share)

 

 

 

Basic

(5.8)

(9.3)

(13.8)

Diluted

(5.8)

(9.3)

(13.8)

 

The Group was loss making for the periods ended 31 January 2018 and 31 January 2017 and also for the year ended 31 July 2017. Therefore, the dilutive effect of share options has not been taken account of in the calculation of diluted earnings per share, since this would decrease the loss per share for each of the periods reported.



7 Notes to the cash flow statement


Unaudited

Unaudited

Audited


6 months to

6 months to

year ended


31 January

31 January

31 July


2018

2017

2017


£'000

£'000

£'000

Loss for the period attributable to equity shareholders

(2,291)

(2,053)

(3,043)

Tax on loss

-

-

(1,234)

Net finance income

(20)

(22)

(33)

Depreciation of property, plant and equipment

154

118

251

Exceptional costs

205

-

-

EBITDA

(1,952)

(1,957)

(4,059)

Depreciation of property, plant and equipment

(154)

(118)

(251)

Exceptional costs

(205)

-

-

Operating loss

(2,311)

(2,075)

(4,310)

Depreciation of tangible fixed assets

154

118

251

IFRS 2 share based payments charge

138

78

192

(Increase)/Decrease in net working capital

21

(161)

(95)

Net cash used within operations

(1,998)

(2,040)

(3,962)

 

8 Share capital


Unaudited

Unaudited


number

total


of Ordinary shares

£'000

Allotted, called up and fully paid

 

 

At 31 July 2016 Ordinary shares of 2 pence each

21,872,551

437

Issued on 18 August 2016

166,204

3

Issued on 4 November 2016

83,102

2

Issued on 26 May 2017

168,906

4

At 31 July 2017 Ordinary shares of 2 pence each

22,290,763

446

Issued on 31 October 2017

27,138,617

543

At 31 January 2018 Ordinary shares of 2 pence each

49,429,380

989

 

On 18 August 2016, 166,204 Ordinary shares of 2 pence each were issued at a price of £0.583 per share to satisfy the exercise of EMI share options.

On 4 November 2016, 83,102 Ordinary shares of 2 pence each were issued at a price of £0.583 per share to satisfy the exercise of EMI share options.

On 26 May 2017, 168,906 Ordinary shares of 2 pence each were issued at a price of £1.55 per share following the exercise of warrants.

On 31 October 2017, 21,138,617 Ordinary shares of 2 pence each were issued at a price of £0.36 per share to institutional and other investors.

 



9 Related party transactions

Transactions between Applied Graphene Materials plc and its subsidiaries, which are related parties, have been eliminated on consolidation and are not disclosed in this note.

 

Transactions with shareholders

The following transactions with shareholders of the Group were recorded, excluding VAT, during the period:

 


Unaudited

Unaudited

Audited


6 months to

6 months to

year ended


31 January

31 January

31 July


2018

2017

2017


£'000

£'000

£'000

University of Durham (shareholder)

 

 

 

Staff secondment, consultancy and other fees

20

22

57

Top Technology Limited (controlled by shareholder)

 

 

 

Non-Executive fees and expenses

8

8

16

Corporate finance fees

20

-

-

 

 

 

 

Remuneration of key management personnel

The remuneration of the Directors, who are the key management personnel of the Group, is set out below in aggregate for each of the categories specified in IAS 24 Related Party Disclosures:


Unaudited

Audited


6 months to

year ended


31 January

31 July


2018

2017

2017


£'000

£'000

Short term employee benefits (excluding bonuses)

338

303

643

Payments to third parties

8

8

15

IFRS 2 share based payments charge

138

78

146

 

484

389

804

 

10 Seasonality

The Group experiences no material variations in performance arising due to seasonality.

 

11 Availability of Interim Report

It is anticipated that the Interim Report will be sent to all shareholders on 27 April 2018. Electronic copies of the report will also be available on Applied Graphene Materials' website at www.appliedgraphenematerials.com.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR UKAORWUASRUR

Related Charts

Applied Graphene Materials (AGM)

-0.50p (-1.05%)
delayed 16:57PM